Beijing DaBeiNong Technology Group Co., Ltd. 2025 Board of Directors Work Report
In 2025, the Board of Directors strictly followed the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Shenzhen Stock Exchange Stock Listing Rules," "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 1 – Standardized Operation of Main Board Listed Companies," and other laws and regulations, as well as the "Articles of Association of Beijing DaBeiNong Technology Group Co., Ltd." and "Rules of Procedure for Board Meetings." With a sense of responsibility to the company's shareholders, the Board diligently fulfilled its duties, protected the company's interests, and further improved and standardized the company's operations. The 2025 work of the Board of Directors is hereby reported as follows:
I. Company Business Overview
The company's main businesses include the production and sales of products related to seeds, feed, pigs, and vaccines. In 2025, the company achieved operating revenue of 2,911,893.48 million yuan, a year-on-year increase of 1.22%; net profit was -48,805.14 million yuan, and net profit attributable to shareholders of the listed company was -64,152.40 million yuan. In 2025, the sales volume, revenue, and net profit of the company's seed business all increased; the sales volume of feed and pig farming business increased, but profitability declined due to market environment and pig price fluctuations. In addition, in accordance with accounting standards, the company conducted impairment tests on long-term equity investments, biological assets, and goodwill. Affected by the sluggish live pig market and the failure of invested entities to meet expected operating performance, the net realizable value or recoverable amount of the company's inventory live pigs, long-term equity investments, and goodwill at the end of the year was lower than their book value, and impairment losses were recognized for these assets.